NO20041058L - Preparations and Methods Related to New Benzodiazepine Compounds and Forms thereof - Google Patents
Preparations and Methods Related to New Benzodiazepine Compounds and Forms thereofInfo
- Publication number
- NO20041058L NO20041058L NO20041058A NO20041058A NO20041058L NO 20041058 L NO20041058 L NO 20041058L NO 20041058 A NO20041058 A NO 20041058A NO 20041058 A NO20041058 A NO 20041058A NO 20041058 L NO20041058 L NO 20041058L
- Authority
- NO
- Norway
- Prior art keywords
- preparations
- forms
- methods related
- benzodiazepine compounds
- new benzodiazepine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31256001P | 2001-08-15 | 2001-08-15 | |
| US31368901P | 2001-08-20 | 2001-08-20 | |
| US39667002P | 2002-07-18 | 2002-07-18 | |
| US10/217,878 US20030119029A1 (en) | 1999-04-30 | 2002-08-13 | Compositions and methods relating to novel benzodiazepine compounds and targets thereof |
| PCT/US2002/026171 WO2003015703A2 (en) | 2001-08-15 | 2002-08-15 | Compositions and methods relating to novel benzodiazepine compounds and targets thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20041058L true NO20041058L (en) | 2004-05-14 |
Family
ID=27499087
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20041058A NO20041058L (en) | 2001-08-15 | 2004-03-12 | Preparations and Methods Related to New Benzodiazepine Compounds and Forms thereof |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1423122A4 (en) |
| JP (1) | JP2005502652A (en) |
| AU (1) | AU2002332560B2 (en) |
| CA (1) | CA2457405A1 (en) |
| MX (1) | MXPA04001421A (en) |
| NO (1) | NO20041058L (en) |
| NZ (1) | NZ531117A (en) |
| WO (1) | WO2003015703A2 (en) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000066106A2 (en) | 1999-04-30 | 2000-11-09 | The Regents Of The University Of Michigan | Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
| US20050113460A1 (en) * | 1999-04-30 | 2005-05-26 | The Regents Of The University Of Michigan | Compositions and methods relating to novel compounds and targets thereof |
| US7572788B2 (en) | 1999-04-30 | 2009-08-11 | The Regents Of The University Of Michigan | Compositions and methods relating to novel compounds and targets thereof |
| US7276348B2 (en) | 1999-04-30 | 2007-10-02 | Regents Of The University Of Michigan | Compositions and methods relating to F1F0-ATPase inhibitors and targets thereof |
| US20060025388A1 (en) | 1999-04-30 | 2006-02-02 | Glick Gary D | Compositions and methods relating to novel compounds and targets thereof |
| JP2007500212A (en) * | 2003-05-01 | 2007-01-11 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | Compositions and methods relating to novel compounds and their targets |
| US20050272723A1 (en) * | 2004-04-27 | 2005-12-08 | The Regents Of The University Of Michigan | Methods and compositions for treating diseases and conditions associated with mitochondrial function |
| EP1845996A4 (en) | 2005-01-03 | 2009-04-29 | Univ Michigan | Compositions and methods relating to novel compounds and targets thereof |
| EP1893218A4 (en) * | 2005-06-01 | 2011-01-12 | Univ Michigan | Unsolvated benzodiazepine compositions and methods |
| MX2008003369A (en) | 2005-09-19 | 2008-03-27 | Arrow Therapeutics Ltd | Benzodiazepine derivatives for treating hepatitis c infection. |
| AU2006308655B2 (en) * | 2005-11-01 | 2010-09-23 | The Regents Of The University Of Michigan | Novel 1,4-benzodiazepine-2,5-diones with therapeutic properties |
| US7759338B2 (en) | 2006-04-27 | 2010-07-20 | The Regents Of The University Of Michigan | Soluble 1,4 benzodiazepine compounds and stable salts thereof |
| NZ573452A (en) | 2006-06-09 | 2011-09-30 | Univ Michigan | Compositions and methods relating to novel compounds and targets thereof |
| US7851465B2 (en) | 2007-03-09 | 2010-12-14 | The Regents Of The University Of Michigan | Compositions and methods relating to novel compounds and targets thereof |
| ES2614498T3 (en) | 2007-09-14 | 2017-05-31 | The Regents Of The University Of Michigan | ATPase F1F0 inhibitors and related methods |
| BRPI0820477A2 (en) | 2007-11-06 | 2015-06-16 | Univ Michigan | Benzodiazepinone compounds useful in the treatment of skin disorders |
| JP5567573B2 (en) | 2008-09-11 | 2014-08-06 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | Arylguanidine F1F0-ATPase inhibitors and methods related thereto |
| US8604023B2 (en) | 2009-04-17 | 2013-12-10 | The Regents Of The University Of Michigan | 1,4-benzodiazepinone compounds and their use in treating cancer |
| EP2470020A4 (en) | 2009-09-18 | 2013-03-13 | Univ Michigan | Benzodiazepinone compounds and methods of treatment using same |
| US9126978B2 (en) | 2009-11-17 | 2015-09-08 | The Regents Of The University Of Michigan | 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties |
| CA2780287C (en) | 2009-11-17 | 2015-03-17 | The Regents Of The University Of Michigan | 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4898861A (en) * | 1987-03-26 | 1990-02-06 | Hoffmann-La Roche Inc. | Method for inhibiting the proliferation of tumor cells |
| WO2000066106A2 (en) * | 1999-04-30 | 2000-11-09 | The Regents Of The University Of Michigan | Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
| US5776946A (en) * | 1995-08-28 | 1998-07-07 | Mcgeer; Patrick L. | Peripheral benzodiazepine receptor ligands as antiinflammatory agents |
| WO1999058117A1 (en) * | 1998-05-13 | 1999-11-18 | Sanofi-Synthelabo | Use of compounds for reducing apoptosis |
| FR2779963A1 (en) * | 1998-06-22 | 1999-12-24 | Centre Nat Rech Scient | New composition useful for treat cancer, comprises compound with affinity for mitochondrial benzodiazepine receptors and agent to induce apoptosis |
| US6277844B1 (en) * | 1998-09-14 | 2001-08-21 | Sydney Spector | Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis |
| WO2000079274A2 (en) * | 1999-06-22 | 2000-12-28 | Mitokor | Methods for assaying subcellular conditions using energy transfer |
| US7005274B1 (en) * | 1999-09-15 | 2006-02-28 | Migenix Corp. | Methods and compositions for diagnosing and treating arthritic disorders and regulating bone mass |
| WO2001051922A2 (en) * | 2000-01-14 | 2001-07-19 | Mitokor | Identification of peripheral benzodiazepine receptor binding agents |
-
2002
- 2002-08-15 WO PCT/US2002/026171 patent/WO2003015703A2/en active IP Right Grant
- 2002-08-15 CA CA002457405A patent/CA2457405A1/en not_active Abandoned
- 2002-08-15 EP EP02794914A patent/EP1423122A4/en not_active Withdrawn
- 2002-08-15 NZ NZ531117A patent/NZ531117A/en not_active IP Right Cessation
- 2002-08-15 JP JP2003520664A patent/JP2005502652A/en active Pending
- 2002-08-15 AU AU2002332560A patent/AU2002332560B2/en not_active Ceased
- 2002-08-15 MX MXPA04001421A patent/MXPA04001421A/en not_active Application Discontinuation
-
2004
- 2004-03-12 NO NO20041058A patent/NO20041058L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2457405A1 (en) | 2003-02-27 |
| NZ531117A (en) | 2006-03-31 |
| JP2005502652A (en) | 2005-01-27 |
| WO2003015703A2 (en) | 2003-02-27 |
| WO2003015703A3 (en) | 2003-11-13 |
| AU2002332560B2 (en) | 2006-01-19 |
| MXPA04001421A (en) | 2004-06-03 |
| EP1423122A2 (en) | 2004-06-02 |
| EP1423122A4 (en) | 2008-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20041058L (en) | Preparations and Methods Related to New Benzodiazepine Compounds and Forms thereof | |
| DK1417175T3 (en) | SUBSTITUTED DIHYDRO-3-HALO-1H-PYRAZOL-5-CARBOXYLATES AND PREPARATION AND USE THEREOF | |
| DK1370128T3 (en) | Combined baler and baler | |
| NO20035325D0 (en) | Skin permeable selective cyclooxygenase-2 inhibitor preparation | |
| DK1746375T3 (en) | Oxygen-fueled combustion system and uses thereof | |
| CY2013011I2 (en) | METHOD OF ADMINISTRATION OF DIPHOSPHONICS | |
| IS7188A (en) | Azabycyclic-substituted conjugated heteroaryl compounds, their method of preparation and use | |
| NO20044192L (en) | 17alpha-alkyl-17beta-oxy-ostratrienes and pharmaceutical preparations | |
| NO20040072L (en) | New substituted benzimidazole dosage forms and methods for using the same | |
| DK1390389T3 (en) | Crypto-blocking antibodies and uses thereof | |
| NO20033387D0 (en) | Modified antibodies and methods of use | |
| DK1539224T3 (en) | Antimicrobial preparation and method of use | |
| DK1511734T3 (en) | Compounds, Preparations and Methods | |
| NO20032332L (en) | Benzodiazepine derivative compounds, method of preparation and use thereof | |
| IS7798A (en) | Compounds, pharmaceutical preparations and methods | |
| ID30187A (en) | DONGKRAK KIND OF PANTAGRAF | |
| DK1429769T3 (en) | New formulations and their use | |
| NO20033854L (en) | N-but-3-enyl-norbuprenorphine and methods of use | |
| IS6401A (en) | Chemical methods and intermediates | |
| DK1311731T3 (en) | Procedure and arrangement for post system | |
| NO20035328D0 (en) | New compounds and preparations as catheps inhibitors | |
| NO20033506D0 (en) | Parasite-killing preparations and methods of use | |
| NO20030843D0 (en) | Device and method of cultivation | |
| NO20030822D0 (en) | New compounds and methods | |
| NO20030156L (en) | Pharmaceutical compositions and methods for their use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |